NewEdge Wealth’s Biohaven BHVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.66M Sell
245,670
-833
-0.3% -$8.97K 0.04% 311
2026
Q1
$2.09M Hold
246,503
0.02% 412
2025
Q4
$2.78M Sell
246,503
-50
-0% -$619 0.03% 366
2025
Q3
$2.06M Buy
246,553
+3,050
+1% +$44.4K 0.03% 391
2025
Q2
$3.71M Sell
243,503
-29
-0% -$517 0.06% 255
2025
Q1
$5.85M Sell
243,532
-14
-0% -$494 0.11% 159
2024
Q4
$9.1M Sell
243,546
-59
-0% -$2.75K 0.16% 118
2024
Q3
$12.2M Buy
243,605
+102
+0% +$3.97K 0.22% 98
2024
Q2
$8.45M Hold
243,503
0.18% 115
2024
Q1
$9.72M Hold
243,503
0.22% 111
2023
Q4
$10.4M Hold
243,503
0.27% 95
2023
Q3
$6.33M Hold
243,503
0.2% 118
2023
Q2
$5.82M Hold
243,503
0.19% 120
2023
Q1
$3.33M Buy
+243,503
New +$3.88M 0.13% 150

Other funds holding BHVN

NewEdge Wealth's BHVN Position: Q2 2026 in Review

NewEdge Wealth reduced its Biohaven (BHVN) stake by 0.34% in Q2 2026, selling an estimated $8.97K and leaving 245,670 shares worth $3.66M. The position accounts for 0.04% of the portfolio, ranked #311.

NewEdge Wealth first reported a position in BHVN in Q1 2023 and has held it in 14 quarters since. The position peaked at $12.2M in Q3 2024. 293 funds tracked by Wall St. Rank hold BHVN as of Q2 2026.

  • NewEdge Wealth held 245,670 shares of Biohaven worth $3.66M as of Q2 2026.
  • NewEdge Wealth sold 833 Biohaven shares in Q2 2026, an estimated $8.97K.
  • Biohaven made up 0.04% of NewEdge Wealth's portfolio in Q2 2026, its #311 holding.
  • NewEdge Wealth first reported a position in Biohaven in Q1 2023 and has held it in 14 quarters since.
  • NewEdge Wealth's Biohaven position peaked at $12.2M in Q3 2024.
  • 293 funds tracked by Wall St. Rank held Biohaven as of Q2 2026.

Based on NewEdge Wealth's 13F filing for Q2 2026, filed 10 Aug 2026.